You just read:

European Respiratory Journal Publishes Phase II Study of Investigational Oral Agent Riociguat in Treatment of Pulmonary Hypertension

News provided by

Bayer HealthCare Pharmaceuticals, Inc.

Jun 11, 2010, 09:10 ET